C12Y 304/24056
Insulysin
Official title: Insulysin (3.4.24.56)
C12Y304/24056 (Insulysin) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 7
- Assignees
- 7
- Inventors
- 25
- Latest grant
- 17 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Peptide inhibitors of insulin-degrading enzyme17 Jan 2023US 11,555,055 B2The Regents of the University of California
- Mutant insulin degrading enzyme and methods of use21 Jan 2014US 8,632,989 B1University of Kentucky Research Foundation
- Insulin degrading enzyme crystals13 Nov 2012US 8,309,340 B2Hoffmann-La Roche Inc.
- Targeted degradation and removal of amyloid beta plaques for the prevention and treatment of alzheimer’s diseases via engineered nano-scavenger exosomes13 Mar 2025US 2025/0082775 A1Santa Clara University
- Tool and method for disaggregation of polyq stretch-containing proteins3 Oct 2024US 2024/0327817 A1Universität zu Köln
- Peptide inhibitors of insulin-degrading enzyme12 Nov 2020US 2020/0354407 A1The Regents of the University of California
- Assay for insulin-degrading enzyme (ide) inhibitors29 Sep 2016US 2016/0282364 A1President and Fellows of Harvard College
- Apheresis, administration of agent, or combination thereof10 Feb 2011US 2011/0033463 A1Medtronic, Inc.
Most cited
By later US patents